clinicalomicsprowebdirectory
News
Topics
Informatics
Molecular Dx
New Products
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Multimedia
eBooks
Inside Precision Medicine Live
Podcasts
Virtual Event
Webinars
On Demand Webinars
Upcoming Webinars
Subscribe
Create a Free Account
Log In
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Neurological Disorders
Link Between Epstein-Barr Virus and Multiple Sclerosis Strengthened by New Study
Cellular Therapeutics
Mesoblast’s Cell Therapy Proves Effective for Lower Back Pain
Gene Editing
Specificity Of Base Editing Improved by Virus-Like Particle Delivery System
Coronavirus
BioNTech Develops Successful SARS-CoV-2 Early Warning System with InstaDeep
Genetic Disorders
Whole Human Genome Sequenced in Just Over Five Hours in New…
Topics
Informatics
Molecular Dx
New Products
Oncology
Patient Care
Precision Medicine
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Marketplace
Multimedia
All
eBooks
Inside Precision Medicine Live
Podcasts
Virtual Event
Webinars
Cancer Testing
Delivering Cancer Care Equity via In-House NGS Testing
Upcoming Webinars
Digital Solutions to Alleviate NASH Clinical Trial Challenges
Cancer Testing
Podcast Series: Comprehensive Genomic Profiling
Virtual Event
Digital Insights to Tumor Biology
Subscribe
Create a Free Account
Log In
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Home
Companies
23andMe
23andMe
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
23andMe
Direct To Consumer Testing for Familial Hypercholesterolemia: Helpful or Misleading?
July 19, 2021
23andMe
23andMe to go Public via VG Acquisition Corp. Merger
February 4, 2021
23andMe
MyoKardia, 23andMe to Create HCM Digital Community
October 25, 2018
23andMe
Seqster, Scripps Research Translational Institute to Study Data Impact on Healthcare...
October 16, 2018
23andMe
23andMe Wins $300M Investment from GSK in Parkinson’s Disease Partnership
July 25, 2018
23andMe
FDA Authorizes First DTC Cancer Risk Test, 23andMe’s GRH Report for...
March 6, 2018
23andMe
23andMe Raises $250M, More Than Doubling Its Total Capital
September 12, 2017
23andMe
23andMe, Grünenthal to Study the Genetics of Pain, with Targeted Treatments...
May 3, 2017
23andMe
FDA Grants Approval for 23andMe’s Direct-to-Consumer Genetic Health Risk Reports
April 7, 2017
23andMe
Direct-to-Consumer Genetic Testing Study Reviews Value and Impact
December 14, 2016
Load more
Featured
Link Between Epstein-Barr Virus and Multiple Sclerosis Strengthened by New Study
January 14, 2022
Mesoblast’s Cell Therapy Proves Effective for Lower Back Pain
January 14, 2022
BioNTech Develops Successful SARS-CoV-2 Early Warning System with InstaDeep
January 13, 2022
Whole Human Genome Sequenced in Just Over Five Hours in New Record
January 13, 2022
New Products
View All
Digital PCR Leverages Microfluidic Array Tech
October 26, 2021
Simplified PCR Cleanup and Plasmid Prep
October 19, 2021
Pharmacogenetics Home Collection Test Kit
October 19, 2021
Load more
![Seqster's health data management platform will be integrated with Scripps Research Translational Institute (SRTI)’s MyGeneRank app in a collaboration designed to promote better healthcare decisions by app users through tracking of medications and lifestyle modifications. [Source: Scripps Research Translational Institute]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1943-324x160.jpeg "Seqster, Scripps Research Translational Institute to Study Data Impact on Healthcare Decisions")
![23andMe has won the FDA’s first authorization for a direct-to-consumer genetic test focused on cancer risk from three mutations on the BRCA1 and BRCA2 genes that are most common in people of Ashkenazi Jewish descent. [PeJo29/Getty Images]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1522-324x160.jpeg "FDA Authorizes First DTC Cancer Risk Test, 23andMe’s GRH Report for BRCA1 and BRCA2 Mutations")
